Sharkey, Howes & Javer’s Bristol-Myers Squibb BMY Stock Holding History

Sharkey, Howes & Javer’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-2,900	Closed	-$132K	–	70
2019 Q2	$132K	Hold	2,900	–	–	0.06%	72
2019 Q1	$138K	Hold	2,900	–	–	0.06%	69
2018 Q4	$151K	Hold	2,900	–	–	0.1%	60
2018 Q3	$180K	Hold	2,900	–	–	0.09%	55
2018 Q2	$160K	Sell	2,900 -1,300	-31%	-$70.2K	0.09%	50
2018 Q1	$265K	Hold	4,200	–	–	0.15%	30
2017 Q4	$257K	Buy	4,200 +1,300	+45%	+$81.3K	0.15%	32
2017 Q3	$189K	Buy	2,900 +1,300	+81%	+$75.9K	0.1%	41
2017 Q2	$89K	Hold	1,600	–	–	0.05%	67
2017 Q1	$87K	Hold	1,600	–	–	0.05%	68
2016 Q4	$94K	Hold	1,600	–	–	0.06%	59
2016 Q3	$86K	Hold	1,600	–	–	0.05%	69
2016 Q2	$118K	Sell	1,600 -240	-13%	-$17K	0.07%	55
2016 Q1	$118K	Buy	1,840 +240	+15%	+$15.1K	0.09%	48
2015 Q4	$110K	Hold	1,600	–	–	0.08%	52
2015 Q3	$95K	Hold	1,600	–	–	0.07%	59
2015 Q2	$106K	Buy	+1,600	New	+$105K	0.08%	41

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sharkey, Howes & Javer's BMY Position: Q3 2019 in Review

Sharkey, Howes & Javer sold out of Bristol-Myers Squibb (BMY) in Q3 2019, closing a stake of 2,900 shares — an estimated $132K sold.

Sharkey, Howes & Javer first reported a position in BMY in Q2 2015 and held it in 17 quarters. The position peaked at $265K in Q1 2018. 1,814 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

Sharkey, Howes & Javer reported no remaining Bristol-Myers Squibb position as of Q3 2019 after selling out during the quarter.
Sharkey, Howes & Javer sold 2,900 Bristol-Myers Squibb shares in Q3 2019, an estimated $132K.
Sharkey, Howes & Javer first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 17 quarters.
Sharkey, Howes & Javer's Bristol-Myers Squibb position peaked at $265K in Q1 2018.
1,814 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Sharkey, Howes & Javer's 13F filing for Q3 2019, filed 1 Nov 2019.